Conference Coverage

Switch back to human insulin a viable money saver

Publish date: June 24, 2018

 

REPORTING FROM ADA 2018

There was no industry funding. Dr. Luo is a consultant for Alosa Health and Health Action International.

SOURCE: Luo J et al. 2018 American Diabetes Association scientific session abstract 4-OR

Pages

Recommended Reading

Thyroid markers linked to risk of gestational diabetes
MDedge Internal Medicine
Type 2 diabetes may promote Parkinson development
MDedge Internal Medicine
NIH cans study that relied on millions in funding from alcohol companies
MDedge Internal Medicine
In T2DM, healthy lifestyle lowers CVD risk, mortality
MDedge Internal Medicine
Diabetic foot ulcer healing is predictable by WIfI stage scores
MDedge Internal Medicine
Ethical violations scuttle NIH’s big alcohol study
MDedge Internal Medicine
FDA okays fully implantable continuous glucose monitor/mobile app combo for diabetes
MDedge Internal Medicine
Patients going without as insulin prices skyrocket
MDedge Internal Medicine
Average glucose, A1c discordance is common, highlights ADAG equation concerns
MDedge Internal Medicine
T1D neuropathy declines as glycemic control improves
MDedge Internal Medicine